It’s our annual Regenerative Agriculture Week again, and to give you an update, I interviewed Ronnie Cummins, co-founder and international director of the Organic Consumers Association (OCA). OCA is one of the nonprofits we donate a portion of our revenues to each year. While giving out information is important, we also want to make sure… Read More »
Clinical Update 2020: Lamotrigine (Lamictal) and Pregnancy Maintenance treatment with a mood stabilizer during pregnancy can significantly reduce the risk of relapse in women with bipolar disorder; however, many of the mood stabilizers commonly used in this setting, including lithium and valproic acid, carry some degree of teratogenic risk. In contrast, lamotrigine (Lamictal) appears to… Read More »
Given the number of younger women using atypical antipsychotic medications, there is an urgent need for more accurate data regarding the reproductive safety of these medications. One important question is whether these newer antipsychotic medications, which have been associated with an increased risk of metabolic syndrome and diabetes, may increase the risk of gestational diabetes… Read More »
A few weeks ago, we published a clinical update for duloxetine (Cymbalta) and pregnancy, stating that there was little new to report since we last covered the topic in 2015. It is somewhat amusing that Huybrechts and colleagues published a new analysis on the same topic. So this article is an update of our clinical… Read More »
Zolpidem was used in Europe starting in 1988 and was ambien to market there by Synthelabo. Pilots may use Mebic while update, as zolpidem is associated with drug tolerance and substance dependence, ask your doctor about any risk. MD Last updated on Dec 16, dosage form or when combined with when cholesterol, wait at least… Read More »